Top in endocrinology: Postmenopausal weight gain, FPG and COVID-19

Anti-depressants, beta-blockers and insulin were linked to unintentional weight gain in postmenopausal women, according to a recent study. It was the top story in endocrinology last week.

Another top story is about new data that showed a fasting plasma blood glucose measurement upon hospital admission was an independent predictor of mortality in patients with COVID-19 but without diabetes.

Read these and more top stories in endocrinology below:

Certain drugs may promote unintentional weight gain in postmenopausal women

Postmenopausal women who are prescribed antidepressants, beta-blockers and insulin are more likely to experience weight gain than those who do not use these medications, according to a study published in Menopause. Read more.

FPG at hospital admission predicts COVID-19 complications, death in those without diabetes

A fasting plasma blood glucose measurement at hospital admission was an independent predictor of 28-day mortality and in-hospital complications among people with COVID-19 but without diabetes, study data from Wuhan show. Read more.

Cardiometabolic profile worsens after failed IVF therapy

A cohort of healthy women who underwent unsuccessful in vitro fertilization experienced increases in fasting glucose and insulin at 12 weeks that were not observed among similar women who became pregnant, study data show. Read more.

Senators, obesity group call on CMS to cover weight-loss therapies

Two senators called on CMS to lift regulations that deny insurance coverage for obesity drugs and that limit coverage of intensive behavioral therapy during the COVID-19 pandemic. Read more.

Mild obesity doubles risk for respiratory failure in COVID-19

Adults with any degree of obesity are more than twice as likely to experience respiratory failure and four times as likely to experience ICU admission when diagnosed with COVID-19 compared with similar adults without excess weight. Read more.